Astellas Pharma Inc. in 2 stories
The narratives 4503.T currently appears in, with its side and exposure in each.
Bull side
0 storiesNo bull-side stories for 4503.T yet.
Bear side
2 stories- America Imports the World's Drug Prices
4503.T in “America Imports the World's Drug Prices”
StableExposure: not rated yetUS reference pricing puts global blockbuster economics—and not just American list prices—under pressure.
Astellas depends heavily on US economics for products including Xtandi, Padcev and Veozah, making international price benchmarking a direct margin threat.
- The Patent Cliff Sparks a Biotech Land Grab
4503.T in “The Patent Cliff Sparks a Biotech Land Grab”
FadingExposure: not rated yetLarge drugmakers facing revenue holes must buy scarce pipelines, turning clinical validation into strategic currency.
Astellas remains dependent on successfully replacing mature blockbuster revenue through a pipeline with meaningful execution risk.